logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
Showing 1 - 2 of 2 Items
Showing 1 - 2 of 2 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Doing no harm? Adverse events in a nation-wide cohort of patients with multidrug-resistant tuberculosis in Nigeria

Avong YK, Isaakidis P, Hinderaker SG, Van der Bergh R, Ali E,  et al.
2015-03-17 • PLOS One
2015-03-17 • PLOS One
Adverse events (AEs) of second line anti-tuberculosis drugs (SLDs) are relatively well documented. However, the actual burden has rarely been described in detail in programmatic settings...
Journal Article
|
Commentary

Early antiretroviral therapy initiation: access and equity of viral load testing for HIV treatment monitoring

Peter T, Ellenberger D, Kim AA, Boeras D, Messele T,  et al.
2016-10-20 • Lancet Infectious Diseases
2016-10-20 • Lancet Infectious Diseases
Scaling up access to HIV viral load testing for individuals undergoing antiretroviral therapy in low-resource settings is a global health priority, as emphasised by research showing the ...